Key result
Elevated angiogenin linked to ~3.9-fold higher risk of non-fatal major cardiovascular events in diabetic kidney disease.
Why the study?
Does a machine-learning-derived plasma multi-protein panel improve the prediction of incident non-fatal major adverse cardiovascular events in patients with diabetic kidney disease?
Cohort (n=317)
Yes
Does a machine-learning-derived plasma multi-protein panel improve the prediction of incident non-fatal major adverse cardiovascular events in patients with diabetic kidney disease?
Answers are grounded in this paper and cite their sources.
Integrating a 9-protein plasma signature with clinical variables improves 10-year prediction of non-fatal MACE, MI, and stroke in patients with diabetic kidney disease compared to traditional clinical risk factors alone.
Objective: To identify plasma protein biomarkers associated with incident non-fatal major adverse cardiovascular events (MACE) in diabetic kidney disease (DKD) patients. Research design and methods: We analyzed 317 DKD patients from the UK Biobank. Plasma proteomics and clinical data (demographics, metabolism, renal function) were integrated. In an exploratory discovery phase, three sequential Cox regression models (crude, socio-demographic-adjusted, socio-demographic-metabolic adjusted) screened non-fatal MACE-associated proteins. To prevent information leakage, the cohort was then randomly split into training (70%) and testing (30%) sets; machine-learning feature selection, hyperparameter optimization, and final model development were performed exclusively within the training set. The associated proteins were input into the four-step machine-learning pipeline (LASSO-Cox, random survival forest, Boruta, XGBoost-Cox). Predictive performance was validated using Kaplan-Meier survival analyses, longitudinal trajectory modeling, and ROC benchmarking. An interactive web application was deployed for clinical implementation. Results: Of 1,463 plasma proteins, 561 were associated with non-fatal MACE across Cox models, with 14 overlapping proteins. Nine core proteins (ANG, IL1R1, CXCL14, ESAM, PTGDS, HAVCR1, FGFR2, IGSF8, CCL3) were validated: ANG showed the strongest non-fatal MACE association (HR = 3.88, 95%CI 2.33-6.48, p<0.001), and all high-expression groups had elevated non-fatal MACE risk. GO/KEGG enrichment highlighted inflammatory-immune pathways like positive regulation of MAPK cascade, Cytokine-cytokine receptor interaction and PI3K-Akt signaling pathway as key mechanisms. The model integrating proteins, demographic factors, and clinical variables achieved the highest predictive performance across non-fatal MACE (AUC = 0.768), myocardial infarction (MI) (0.808), and stroke (0.816) outcomes, with superior stability in cross-validation. CoxBoost + Elastic Net framework was selected as the optimal framework via benchmarking of 101 algorithms. The model demonstrated favorable calibration in high-risk patients and yielded positive net clinical benefit across decision thresholds of 5% to 45%. The web tool (https://jiangli2941.github.io/MACE-prediction-v2/) enables input of 28 variables, outputs non-fatal MACE risk status, risk probability, and highlights abnormal indicators. Conclusion: Plasma proteomics combined with machine learning identifies robust non-fatal MACE predictors in DKD.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) conducted a cohort in Diabetic kidney disease (n=317). Nine-protein plasma panel (ANG, IL1R1, CXCL14, ESAM, PTGDS, HAVCR1, FGFR2, IGSF8, CCL3) with elevated ANG expression vs. Low baseline protein expression / demographic and clinical risk factors alone was evaluated on Incident non-fatal major adverse cardiovascular events (MACE), defined as non-fatal myocardial infarction or non-fatal stroke (HR 3.88, 95% CI 2.33-6.48, p=<0.001). Elevated plasma angiogenin (ANG) strongly predicted incident non-fatal major cardiovascular events in diabetic kidney disease, and a 9-protein clinical model achieved an AUC of 0.768.
Synapse has enriched 10 related papers. Consider them for comparative context: